195 related articles for article (PubMed ID: 2570758)
1. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
Silke B; Guy S; Humphreys JE
J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
[TBL] [Abstract][Full Text] [Related]
4. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
[TBL] [Abstract][Full Text] [Related]
5. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S; Monk JP
Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
[TBL] [Abstract][Full Text] [Related]
6. Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study.
Shionoiri H; Gotoh E; Ito T; Hata T; Iwatsubo H; Takegawa K; Ogihara T; Mikami H; Ikegami H; Otsuka A
Am J Med Sci; 1994 Feb; 307 Suppl 1():S91-5. PubMed ID: 7908168
[TBL] [Abstract][Full Text] [Related]
7. [Pressure and metabolic effects of terazosin in essential hypertension].
Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
[TBL] [Abstract][Full Text] [Related]
8. Terazosin: a new alpha adrenoceptor blocking drug.
Achari R; Laddu A
J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083
[TBL] [Abstract][Full Text] [Related]
9. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia].
Ponikowski P; Hańczycowa H; Sebzda T; Jurga M; Spring A; Rotter A; Jordanek P
Wiad Lek; 1993 Apr; 46(7-8):250-4. PubMed ID: 7902632
[TBL] [Abstract][Full Text] [Related]
10. A multicentre, hospital study of the efficacy and safety of terazosin and its effects on the plasma cholesterol levels of patients with untreated essential hypertension.
Lytle T; Coles S; Waite MA
J Hum Hypertens; 1991 Feb; 5(1):35-8. PubMed ID: 1674964
[TBL] [Abstract][Full Text] [Related]
11. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
Holtzman JL; Kaihlanen PM; Rider JA; Lewin AJ; Spindler JS; Oberlin JA
Arch Intern Med; 1988 Mar; 148(3):539-43. PubMed ID: 3277569
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure and lipid lowering effects of terazosin.
Rosenthal J
J Hum Hypertens; 1989 Dec; 3 Suppl 2():85-9; discussion 90-1. PubMed ID: 2575179
[TBL] [Abstract][Full Text] [Related]
13. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
Kincaid-Smith P
J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes during antihypertensive therapies.
Krone W; Nägele H
J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
[TBL] [Abstract][Full Text] [Related]
15. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension.
Beretta-Piccoli C; Ferrier C; Weidmann P
J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial.
Liu H; Liu P; Mao G; Chen G; Wang B; Qin X; Na Y; Liu Z; Wang X; Xu X
Urology; 2009 Jul; 74(1):130-6. PubMed ID: 19371934
[TBL] [Abstract][Full Text] [Related]
18. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
[TBL] [Abstract][Full Text] [Related]
19. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
20. Effects of terazosin on serum lipid levels in hypertensive blacks.
Luther RR; Klepper MJ; Maurath CJ; Glassman HN; Achari R; Laddu AR
J Hum Hypertens; 1990 Apr; 4(2):154-6. PubMed ID: 1971028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]